(Q41451817)

30 September 2017

title

Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA. (English)

1 reference

30 September 2017

main subject

anti-retroviral agent

0 references

12

Christine Rouzioux

1 reference

30 September 2017

Moussa Laanani

1

0 references

Cécile Goujard

10

object named as

Cécile Goujard

1 reference

30 September 2017

11

Laurence Meyer

1 reference

30 September 2017

9

Pierre-Marie Girard

1 reference

30 September 2017

Jade Ghosn

2

1 reference

30 September 2017

Asma Essat

3

1 reference

30 September 2017

Adeline Melard

4

1 reference

30 September 2017

Rémonie Seng

5

1 reference

30 September 2017

Marine Gousset

6

1 reference

30 September 2017

Henri Panjo

7

1 reference

30 September 2017

Emmanuel Mortier

8

1 reference

30 September 2017

Agence Nationale de Recherche sur le Sida PRIMO Cohort Study Group

13

1 reference

30 September 2017

language of work or name

English

0 references

publication date

3 March 2015

1 reference

Clinical Infectious Diseases

30 September 2017

published in

1 reference

30 September 2017

volume

60

1 reference

30 September 2017

issue

11

1 reference

30 September 2017

page(s)

1715-1721

1 reference

Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Impact of 48 week lopinavir/ritonavir monotherapy on blood cell-associated HIV-1-DNA in the MONARK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Predictors of Plasma Human Immunodeficiency Virus Type 1 RNA Control after Discontinuation of Highly Active Antiretroviral Therapy Initiated at Acute Infection Combined with Structured Treatment Interruptions and Immune‐Based Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Stimulation of the primary anti-HIV antibody response by IFN-alpha in patients with acute HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Immune activation and inflammation in HIV-1 infection: causes and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Phenotype and function of human T lymphocyte subsets: consensus and issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

HIV-1 DNA predicts disease progression and post-treatment virological control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

Factors Associated With Virological Failure in HIV-1–Infected Patients Receiving Darunavir/Ritonavir Monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV171

21 January 2018

Identifiers

DOI

10.1093/CID/CIV171

1 reference

30 September 2017

1 reference